You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三諾生物(300298.SZ):2019年度計提商譽減值2500萬元-5000萬元 淨利預降0%-25%
格隆匯 01-17 21:42

格隆匯1月17日丨三諾生物(300298.SZ)披露2019年年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為約2.33億元-約3.1億元,同比下降0%-25%。

2019年度,公司歸屬於上市公司股東的淨利潤預計同比下降的主要原因如下:

1、結合公司及全資子公司PTS公司實際經營情況、戰略規劃及行業市場變化等影響,根據《企業會計準則第8號-資產減值》及相關會計政策規定,公司在2019年度報告中對商譽進行系統性減值測試。經公司財務部門與中介機構謹慎判斷,預計本期計提的商譽減值總額為2500萬元至5000萬元,最終商譽減值準備計提的金額將由公司聘請的具備證券期貨從業資格的評估機構及審計機構進行評估和審計後確定。

2、公司參股子公司深圳市心諾健康產業投資有限公司支付利息費用,及其全資子公司美國Trividia Health Inc.受市場環境及國際銷售等因素影響,2019年處於經營虧損狀態,對母公司的投資收益影響約-6000萬元至-7500萬元。

3、2018年1月,公司完成收購三諾健康管理有限公司64.98%股份,在合併日對原持有的35.02%股權按公允價值重新計量,確認了股權增值部分的投資收益2314.32萬元。

4、2019年度公司共收到軟件產品增值税退税的政府補助資金較2018年同期減少1652.60萬元。

5、剔除上述1-4項因素影響,公司2019年淨利潤較上年同期繼續保持穩定增長。

6、2019年度公司非經常性損益預計約為2500萬元至3000萬元,上年同期約為4521.75萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account